Actively Recruiting
Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions
Led by Norwegian Institute of Public Health · Updated on 2022-03-02
390
Participants Needed
1
Research Sites
780 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with two digital interventions for cancer stress management, cognitive based stress management (CBSM) and mindfulness based intervention (MBI), as well as a control group. 3. The goal is to determine whether digital CBSM or MBI can effectively reduce stress levels as compared to a control group. Second, whether these interventions can improve HRQoL (or avoid onset of HRQoL problems) for patients with breast cancer, compared to a control group.
CONDITIONS
Official Title
Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First occurrence breast cancer diagnosed from January 1, 2020
- Non-metastatic cancer stage 0 to III
- Invasive tumors must be HER2 positive (regardless of ER, PR) or ER negative
- May later include other ER positive if not conflicting with other recruitment
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cancer Registry of Norway
Oslo, Norway, 0379
Actively Recruiting
Research Team
G
Giske Ursin, MD, PhD
CONTACT
I
Ine M Larsson
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here